Market revenue in 2023 | USD 9.2 million |
Market revenue in 2030 | USD 14.7 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Total laparoscopic hysterectomy (tlh) |
Fastest growing segment | Laparoscopic Supracervical Hysterectomy (LSH) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Total Laparoscopic Hysterectomy (TLH), Laparoscopic Supracervical Hysterectomy (LSH), Laparoscopically Assisted Vaginal Hysterectomy (LAVH), Sacrocolpopexy |
Key market players worldwide | Johnson & Johnson, The Cooper Companies Inc, B. Braun Medical, Karl Storz, Conmed Corp, RUDOLF Medical, LiNA, Richard Wolf, Utah Medical Products Inc, PURPLE SURGICAL MANUFACTURING LIMITED, Conkin Surgical Instruments, Laborie Medical Technologies, Bissinger, The O.R. Company, LSI Solutions |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to uterine manipulation devices market will help companies and investors design strategic landscapes.
Total laparoscopic hysterectomy (tlh) was the largest segment with a revenue share of 38.04% in 2023. Horizon Databook has segmented the UK uterine manipulation devices market based on total laparoscopic hysterectomy (tlh), laparoscopic supracervical hysterectomy (lsh), laparoscopically assisted vaginal hysterectomy (lavh), sacrocolpopexy covering the revenue growth of each sub-segment from 2018 to 2030.
The UK uterine manipulation devices market is expected to witness considerable growth over the forecast period due to the growing number of patients suffering from endometrial conditions, especially uterine fibroids and uterine cancer. According to the International Agency for Research on Cancer, in 2022, about 10,440 cases of Corpus uteri cancer were reported in the country, with around 2,695 associated deaths in the same year.
Hysteroscopy procedures are performed for various uterine abnormalities, such as removing polyps & fibroids and treating uterine cancer. Furthermore, England witnesses the highest number of new uterine cancer cases annually. Hence, the rising prevalence of these conditions is expected to support market growth over the coming decade. In the UK, a significant number of women undergo hysterectomy procedures annually, primarily for benign conditions.
According to an article published in BMJ Open in 2023, around 30,000 women undergo a hysterectomy annually in the UK, with the majority of these procedures being performed for benign indications. These benign conditions include abnormal uterine bleeding, pelvic pain, and other related symptoms.
Horizon Databook provides a detailed overview of country-level data and insights on the UK uterine manipulation devices market , including forecasts for subscribers. This country databook contains high-level insights into UK uterine manipulation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account